Abstract:BACKGROUND: Ketamine is a kind of frequently used general venous anesthesia drug in clinic, and the medication in vein or epidural cavum has analgesic effect. It is N-methyl-D-aspartic acid (NMDA) receptor noncompetitive antagonist, which can inhibit toxic effect of excitatory amino acids. OBJECTIVE: To observe effect of ketamine on apoptosis of dorsal horn astrocytes of spinal cord of rats induced by NMDA receptor over activation and explore its possible mechanism of action. DESIGN: Randomized controlled observation. SETTING: Department of Anesthesiology, Taihe Hospital Affiliated to Yunyang Medical College. MATERIALS: The experiment was conducted at Cell Biology Laboratory, Institute of Basic Medical Sciences, Yunyang Medical College between September 2003 and January 2005. Neonatal Wistar rats of two or three days were provided by Animal Experimental Center of Wuhan University. METHODS: Primary astrocytes in dorsal horn of T11-L6 spinal cord of Wistar rats were purified and cultured. Astrocytes were used in the experiment when its purity coefficient reached 98% assessed by gial fibrillary acidic protein. The cultured cells in 24-well plates were divided randomly into 6 groups (9 portions in each group): ①50 μL Hanks liquor was added into the control group. ②Amount of 100 μmol/L was added into the NMDA group. ③Amount of 1 mmol/L was added into the ketamine group. ④100 μmol/L NMDA + 0.1 mmol/L ketamine group. ⑤100 μmol/L NMDA + 0.5 mmol/L ketamine group. ⑥100 μmol/L NMDA + 1 mmol/L ketamine group. 1 mmol/L ketamine was clinical antalgic dosage. Activity of superoxide dismutase (SOD) and content of malondialdehyde (MDA) were examined after 24-hour culture. Content of Bcl-2 protein and change of morphology were observed with immunocytochemistry. Apoptosis of astrocytes was measured with flow cytometry. MAIN OUTCOME MEASURES: ①Counterstain cell staining and changes of morphology of Bcl-2 protein with immunohistochemical method and hematoxylin-esoin staining (HE). ②Apoptosis of astrocytes was detected with flow cytometry. ③Content of MDA and activity of SOD. RESULTS: ①Mean absorbance (A) of Bcl-2 as expression of Bcl-2 protein measured semiquantitatively: It was lower in the 100 μmol/L NMDA group than the control group, which had significant difference [0.054±0.021, 0.108±0.039, respectively, P < 0.01]. It was higher in the 100 μmol/L NMDA + 1 mmol/L ketamine group than the 100 μmol/L NMDA group, which had significant difference [0.148±0.045, 0.054±0.021, respectively, P < 0.01]. ②Apoptosis of astrocytes detected with flow cytometry: It was higher in the 100 μmol/L NMDA group than the control group, which had significant difference [(25.26±6.13)%,(5.66±2.24)%, respectively, P < 0.01]. It was lower in the 100 μmol/L NMDA + 1 mmol/L ketamine group than in the 100 μmol/L NMDA group, which had significant difference [(24.41±4.82)%,(25.26±6.13)%, respectively, P < 0.01]. ③Content of MDA and activity of SOD: 100 μmol/L NMDA made the content of MDA in astrocytes obviously increase , while the activity of SOD markedly decrease. 1 mmol/L ketamine remarkably decreased the content of MDA, distinctly increased the activity of SOD. This effectiveness had evidently dosage-effect relationship in clinical antalgic dosage, which had obviously difference as compared with that of the NMDA group (P < 0.01). The differences between the 1 mmol/L ketamine group and the control group as well as between the 100 μmol/L NMDA + 0.1 mmol/L ketamine group and the NMDA group had insignificant difference. CONCLUSION: NMDA receptor over activation can induce apoptosis of a great number of astrocytes in spinal dorsal horn of rats. Suitable ketamine dramatically inhibits apoptosis, and its mechanism can enhance the expression of Bcl-2 protein of astrocytes, at the same time inhibit the production of free radical and reinforce the activity of SOD.

Ketamine exerts dual effects on the apoptosis of primary cultured hippocampal neurons from fetal rats in vitro

Effects of ketamine on the neurons apoptosis and NMDAR-2B expression in neonatal rats hippocampal CA3 area

Ketamine-induced Neuronal Damage and Altered N-methyl-D-aspartate Receptor Function in Rat Primary Forebrain Culture.

Mechanisms of Propofol Attenuation of Ketamine-Induced Neonatal Brain Injury

Repeated Ketamine Anesthesia during the Neonatal Period Impairs Hippocampal Neurogenesis and Long-Term Neurocognitive Function by Inhibiting Mfn2-Mediated Mitochondrial Fusion in Neural Stem Cells

Dual Effects of Ketamine

Ketamine-induced Apoptosis in the Mouse Cerebral Cortex Follows Similar Characteristic of Physiological Apoptosis and Can Be Regulated by Neuronal Activity

Ketamine induces hippocampal apoptosis through a mechanism associated with the caspase-1 dependent pyroptosis.

Ketamine Inhibits Neuronal Differentiation by Regulating Brain-Derived Neurotrophic Factor (BDNF) Signaling

Ketamine Exacerbates Cortical Neuroapoptosis under Hyperoxic Conditions by Upregulating Expression of the N-methyl-D-aspartate Receptor Subunit NR1 in the Developing Rat Brain

Effects of Ketamine on Glutamate-Induced Apoptosis of Cultured Rat Spinal Dorsal Horn Neurons and Astrocytes

Relationship Between Extracellular Signal-Regulated Kinase and Ketamine-Induced Apoptosis in Rat Hippocampal Neurons

Effect of ketamine in expressions of NR2A-2C receptor subunits in hippocampal dentate gyrus of neonatal rats

Effects of Low Doses of Ketamine on Pyramidal Neurons in Rat Prefrontal Cortex.

Administration of Ketamine Causes Autophagy and Apoptosis in the Rat Fetal Hippocampus and in PC12 Cells.

Influence of ketamine on astrocyte damage in spinal dorsal horn of rats induced by N-methyl-D-aspartic acid

Neonatal exposure of ketamine inhibited the induction of hippocampal long-term potentiation without impairing the spatial memory of adult rats

Repeated Administration of Ketamine Can Induce Hippocampal Neurodegeneration and Long-Term Cognitive Impairment Via the ROS/HIF-1α Pathway in Developing Rats

Ketamine Enhances Human Neural Stem Cell Proliferation and Induces Neuronal Apoptosis Via Reactive Oxygen Species–Mediated Mitochondrial Pathway

Ketamine Induces Neuronal Apoptosis and Cognitive Disorder Via Mir-199A-5p/hif-1α in Neonatal Rats

Ketamine alters cortical integration of GABAergic interneurons and induces long-term sex-dependent impairments in transgenic Gad67-GFP mice